Status: current, Defined. Date: 31-Jan 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3019071000168115 | Optimark 3.31 g/10 mL injection, 10 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3019081000168117 | Optimark (gadoversetamide 3.31 g / 10 mL) injection, 1 x 10 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Optimark 3.31 g/10 mL injection, 10 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Optimark 3.31 g/10 mL injection, 10 mL vial | Is a | gadoversetamide 3.31 g/10 mL injection, 10 mL vial | true | Inferred relationship | Some | ||
| Optimark 3.31 g/10 mL injection, 10 mL vial | has TPUU | Optimark 3.31 g/10 mL injection, 10 mL vial | true | Inferred relationship | Some | 1 | |
| Optimark 3.31 g/10 mL injection, 10 mL vial | has TP | Optimark | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Optimark 3.31 g/10 mL injection, 10 mL vial | Is a | True | Optimark 3.31 g/10 mL injection, 10 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR